Status and Update on Cardiac Resynchronization Therapy Trials


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Cardiac Electrophysiology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Cazeau S.
        • Leclercq C.
        • Lavergne T.
        • et al.
        Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.
        N Engl J Med. 2001; 344: 873-880
        • Tang A.S.
        • Wells G.A.
        • Talajic M.
        • et al.
        Resynchronization-defibrillation for ambulatory heart failure trial investigators. Cardiac-resynchronization therapy for mild-to-moderate heart failure.
        N Engl J Med. 2010; 363: 2385-2395
        • Linde C.
        • Leclercq C.
        • Rex S.
        • et al.
        Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study.
        J Am Coll Cardiol. 2002; 40: 111-118
        • Auricchio A.
        • Stellbrink C.
        • Sack S.
        • et al.
        Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay.
        J Am Coll Cardiol. 2002; 39: 2026-2033
        • Young J.B.
        • Abraham W.T.
        • Smith A.L.
        • et al.
        Multicenter InSync ICD randomized clinical evaluation (MIRACLE ICD) trial investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
        JAMA. 2003; 289: 2685-2694
        • Moss A.J.
        • Hall W.J.
        • Cannom D.S.
        • et al.
        MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events.
        N Engl J Med. 2009; 361: 1329-1338
        • Abraham W.T.
        • Young J.B.
        • León A.R.
        • et al.
        Multicenter InSync ICD II Study Group. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
        Circulation. 2004; 110: 2864-2868
        • Bristow M.R.
        • Saxon L.A.
        • Boehmer J.
        • et al.
        Comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
        N Engl J Med. 2004; 350: 2140-2150
        • Cleland J.G.
        • Daubert J.C.
        • Erdmann E.
        • et al.
        Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure.
        N Engl J Med. 2005; 352: 1539-1549
        • Glikson M.
        • Nielsen J.C.
        • Kronborg M.B.
        • et al.
        • ESC Scientific Document Group
        2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.
        Eur Heart J. 2021; 42: 3427-3520
        • Kusumoto F.M.
        • Schoenfeld M.H.
        • Barrett C.
        • et al.
        2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
        Circulation. 2019; 140 ([Erratum appears in Circulation 2019;140(8):e506-e508]): e382-e482
        • Auricchio A.
        • Prinzen F.W.
        Enhancing response in the cardiac resynchronization therapy patient: the 3B perspective-bench, bits, and bedside.
        JACC Clin Electrophysiol. 2017; 3: 1203-1219
        • Mullens W.
        • Auricchio A.
        • Martens P.
        • et al.
        Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: a joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology.
        Eur J Heart Fail. 2020; 22: 2349-2369
        • Caputo M.L.
        • van Stipdonk A.
        • Illner A.
        • et al.
        The definition of left bundle branch block influences the response to cardiac resynchronization therapy.
        Int J Cardiol. 2018; 269: 165-169
        • Surawicz B.
        • Childers R.
        • Deal B.J.
        • et al.
        American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; American College of Cardiology Foundation; Heart Rhythm Society. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology.
        J Am Coll Cardiol. 2009; 53: 976-981
        • Brignole M.
        • Pentimalli F.
        • Palmisano P.
        • et al.
        AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
        Eur Heart J. 2021; : ehab569
        • Merkely B.
        • Kosztin A.
        • Roka A.
        • et al.
        Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicentre clinical trial.
        Europace. 2017; 19: 1549-1555
      1. Maffessanti F, Jadczyk T, Kurzelowski R, et al. The influence of scar on the spatio-temporal relationship between electrical and mechanical activation in heart failure patients. Europace. 2020 May 1;22(5):777-786. [Erratum in:Europace 2020;22(5):786].

        • Borgquist R.
        • Carlsson M.
        • Markstad H.
        • et al.
        Cardiac resynchronization therapy guided by echocardiography, MRI, and CT Imaging: a Randomized Controlled Study.
        JACC Clin Electrophysiol. 2020; 6: 1300-1309
        • Singh J.P.
        • Berger R.D.
        • Doshi R.N.
        • et al.
        • ENHANCE CRT Study Group
        Targeted left ventricular lead implantation strategy for non-left bundle branch block patients: the ENHANCE CRT Study.
        JACC Clin Electrophysiol. 2020; 6: 1171-1181
        • Niazi I.
        • Baker 2nd, J.
        • Corbisiero R.
        • et al.
        MPP investigators. safety and efficacy of multipoint pacing in cardiac resynchronization therapy: the MultiPoint Pacing Trial.
        JACC Clin Electrophysiol. 2017; 3: 1510-1518
        • Leclercq C.
        • Gadler F.
        • Kranig W.
        • et al.
        TRIP-HF (triple resynchronization in paced heart failure patients) Study Group. A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure.
        J Am Coll Cardiol. 2008; 51: 1455-1462
        • Pappone C.
        • Ćalović Ž.
        • Vicedomini G.
        • et al.
        Improving cardiac resynchronization therapy response with multipoint left ventricular pacing: twelve-month follow-up study.
        Heart Rhythm. 2015; 12: 1250-1258
        • Osca J.
        • Alonso P.
        • Cano O.
        • et al.
        The use of multisite left ventricular pacing via quadripolar lead improves acute haemodynamics and mechanical dyssynchrony assessed by radial strain speckle tracking: initial results.
        Europace. 2016; 18: 560-567
        • Mehta V.S.
        • Elliott M.K.
        • Sidhu B.S.
        • et al.
        Multipoint pacing for cardiac resynchronisation therapy in patients with heart failure: a systematic review and meta-analysis.
        J Cardiovasc Electrophysiol. 2021; 32: 2577-2589
        • Leclercq C.
        • Burri H.
        • Curnis A.
        • et al.
        Cardiac resynchronization therapy non-responder to responder conversion rate in the more response to cardiac resynchronization therapy with MultiPoint Pacing (MORE-CRT MPP) study: results from Phase I.
        Eur Heart J. 2019; 40: 2979-2987
        • Almusaad A.
        • Sweidan R.
        • Alanazi H.
        • et al.
        Long-term reverse remodeling and clinical improvement by MultiPoint Pacing in a randomized, international, middle Eastern heart failure study.
        J Interv Card Electrophysiol. 2021; (Epub ahead of print)
        • Nunes Ferreira A.
        • Antonio P.S.
        • Aguiar-Ricardo I.
        • et al.
        P578Multipoint pacing in cardiac resynchronization therapy - how to improve remodeling criteria and its impact in quality of life.
        EP Europace. 2020; 22
        • Leyva F.
        • Zegard A.
        • Okafor O.
        • et al.
        Survival after cardiac resynchronization therapy: results from 50 084 implantations.
        Europace. 2019; 21: 754-762
        • Marijon E.
        • Leclercq C.
        • Narayanan K.
        • et al.
        CeRtiTuDe Investigators. Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study.
        Eur Heart J. 2015; 36: 2767-2776
        • McDonagh T.A.
        • Metra M.
        • Adamo M.
        • et al.
        • ESC Scientific Document Group
        2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
        Eur Heart J. 2021; 42: 3599-3726